ORIGINAL RESEARCH
In silico algorithm for optimization of pharmacokinetic studies of [25Mg2+]porphyrin-fullerene nanoparticles
1 Mendeleev University of Chemical Technology, Moscow, Russia
2 Pirogov Russian National Research Medical University, Moscow, Russia
3 Semenov Federal Research Center for Chemical Physics, Moscow, Russia
Correspondence should be addressed: Valentin V. Fursov
Ostrovityanova, 1, Moscow, 117997, Russia; ur.liam@vosrufv
Funding: the study was funded by by the Ministry of Science and Higher Education of the Russian Federation, grant No. 075-15-2020-792 (Unique identifier RF-190220X0031)
Author contribution: Fursov VV — in silico study supervision, concept, hypothesis, structure, modeling, manuscript writing; Zinchenko DI — modeling, code, manuscript writing; Namestnikova DD — in vivo experiments; Kuznetsov DA — general supervision, data interpretation and analysis, planning of experiments.
Compliance with ethical standards: the study was approved by the ethical review board at the Pirogov Russian National Research Medical University (protocol № 140 of 15 December 2014) and the local committee for surveillance of the maintenance and use of laboratory animals (protocol № 13/2020 of 08 October 2020, protocol № 24/2021 of 10 December 2021).